ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | -33.3% | 18,183 | -27.8% | 0.00% | – |
Q2 2022 | $6,000 | -25.0% | 25,183 | -10.6% | 0.00% | – |
Q1 2022 | $8,000 | -20.0% | 28,183 | +55.0% | 0.00% | – |
Q4 2021 | $10,000 | -60.0% | 18,183 | -24.8% | 0.00% | – |
Q3 2021 | $25,000 | -24.2% | 24,183 | 0.0% | 0.00% | – |
Q2 2021 | $33,000 | -19.5% | 24,183 | 0.0% | 0.00% | – |
Q1 2021 | $41,000 | +36.7% | 24,183 | -0.2% | 0.00% | – |
Q4 2020 | $30,000 | 0.0% | 24,238 | +13.9% | 0.00% | – |
Q3 2020 | $30,000 | +66.7% | 21,283 | +39.3% | 0.00% | – |
Q2 2020 | $18,000 | -66.0% | 15,283 | +11.7% | 0.00% | -100.0% |
Q3 2018 | $53,000 | +23.3% | 13,688 | +7.9% | 0.00% | – |
Q2 2018 | $43,000 | +38.7% | 12,688 | -13.6% | 0.00% | – |
Q1 2018 | $31,000 | +3.3% | 14,688 | 0.0% | 0.00% | – |
Q4 2017 | $30,000 | -45.5% | 14,688 | +22.5% | 0.00% | -100.0% |
Q3 2017 | $55,000 | +120.0% | 11,988 | +4.4% | 0.00% | – |
Q2 2017 | $25,000 | -30.6% | 11,478 | +1.6% | 0.00% | -100.0% |
Q1 2017 | $36,000 | +33.3% | 11,295 | +9.7% | 0.00% | 0.0% |
Q4 2016 | $27,000 | -32.5% | 10,295 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $40,000 | – | 10,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |